Schick Technologies has been delisted from the Nasdaq stock exchange, the company has reported. On Sept. 15, Schick received notice from the Nasdaq Listing Qualifications Panel that as of close of business, Schick’s common stock would no longer be
Schick Technologies has been delisted from the Nasdaq stock exchange, the company has reported. On Sept. 15, Schick received notice from the Nasdaq Listing Qualifications Panel that as of close of business, Schicks common stock would no longer be traded on the exchange. The panel attributed its decision to Schicks inability to file its 10-K for fiscal 1999 (end-March) on time, as well as factors discussed in Schicks 8-K, filed on Sept. 2.
Schick will request a review of the panels decision within the 15-day limit required by Nasdaqs marketplace rules, and plans to file its 10-K and its 10-Q for the quarter ended June 30 as soon as the firms new accountants, Grant Thornton, complete their audit of Schicks financial statements. Schicks former accounting firm, PricewaterhouseCoopers, resigned as the companys independent accountants on Aug. 25. Schick will seek relisting on the exchange, or apply for listing on another exchange, once its filings are current with the Securities and Exchange Commission, according to the Long Island City, NY-based company.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.